Morgan Stanley Upgrades Colgate-Palmolive Company (CL) to Overweight
Tweet
Share
E-mailGet Alerts CL Hot Sheet
Price: $92.32 +0.01%
Rating Summary:
18 Buy, 15 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Rating Summary:
18 Buy, 15 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Join SI Premium – FREE
Morgan Stanley analyst Dara Mohsenian upgraded Colgate-Palmolive Company (NYSE: CL) from Equalweight to Overweight with a price target of $72.00 (from $76.00).
For an analyst ratings summary and ratings history on Colgate-Palmolive Company click here. For more ratings news on Colgate-Palmolive Company click here.
Shares of Colgate-Palmolive Company closed at $62.08 yesterday.
You May Also Be Interested In
- Monopar Therapeutics (MNPR) PT Raised to $133 at BTIG
- Riskified Ltd. (RSKD) PT Raised to $5.50 at Goldman Sachs
- Merit Medical Systems, Inc. (MMSI) PT Raised to $97 at BofA Securities
Create E-mail Alert Related Categories
Analyst PT Change, UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
